World ‘on cusp of first treatments for Alzheimer’s disease’ after drug trial

The drug also resulted in 40% less decline in the ability to perform activities of daily living, according to the firm.

A drug has been found to slow down Alzheimer’s disease (Joe Giddens/PA)

The world is “on the cusp of a first generation of treatments for Alzheimer’s disease”, experts have said, as a new drug was found to slow cognitive and functional decline.

The drug donanemab, made by Eli Lilly and Company, slowed decline by 35% to 36% in a late-stage phase 3 clinical trial, the company said.